Autophagy inactivation in osteosarcoma leads to the appearance of poor prognosis-associated factors
Osteosarcoma (OS) is a bone cancer exhibiting a 20% survival rate for metastatic patients, which motivates the development of new therapeutic options. Among the various new treatment approaches, modulation of autophagy is the subject of rising interest. In addition to its pro-survival role in establ...
Main Authors: | Olivier Camuzard, Marie Nollet, Sabine Santucci-Darmanin, Marie-Charlotte Trojani, Nadia Ben Abderrahman, Virginie Virolle, Fanny Burel-Vandenbos, Sophie Pagnotta, François Orange, Ewa Kolano-Merlin, Georges F. Carle, Valérie Pierrefite-Carle |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | Autophagy Reports |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/27694127.2022.2112125 |
Similar Items
-
Autophagy in Osteosarcoma Cancer Stem Cells Is Critical Process which Can Be Targeted by the Antipsychotic Drug Thioridazine
by: Olivier Camuzard, et al.
Published: (2020-12-01) -
Autophagy is a critical process in osteosarcoma cancer stem cells
by: Marie-Charlotte Trojani, et al.
Published: (2021-04-01) -
Role of autophagy in osteosarcoma
by: Olivier Camuzard, et al.
Published: (2019-06-01) -
Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance
by: Mannu K Walia, et al.
Published: (2016-04-01) -
Pathogenesis and Current Treatment of Osteosarcoma: Perspectives for Future Therapies
by: Richa Rathore, et al.
Published: (2021-03-01)